| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.9B | $25.5B | $22.8B | $22.8B | $14.2B | $3.9B | $3.7B | $5.0B |
| Cost of Revenue | $18.6B | $17.8B | $15.1B | $14.0B | $11.7B | $13.1B | $13.4B | $12.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.5B |
| Operating Income | $6.5B | $6.9B | $7.0B | $8.4B | $2.4B | $0.8B | $0.3B | $1.5B |
| Net Income | $4.2B | $4.4B | $4.5B | $5.4B | $0.9B | $0.0B | $0.4B | $1.2B |
| EPS (Basic) | — | — | — | $2.93 | $0.41 | $0.00 | $0.33 | $0.72 |
| EPS (Diluted) | — | — | — | $2.90 | $0.41 | $0.00 | $0.33 | $0.71 |
| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $58.2B | $54.8B | $51.1B | $48.0B | $42.1B | $40.8B | $42.2B | $37.3B |
| Current Assets | $13.8B | $13.3B | $15.6B | $14.8B | $9.3B | $7.9B | $10.7B | $10.8B |
| Cash & Equivalents | $3.8B | $3.9B | $8.1B | $8.1B | $3.7B | $2.0B | $4.2B | $4.4B |
| Total Liabilities | $27.4B | $26.1B | $26.2B | $25.0B | $23.5B | $23.4B | $24.3B | $26.0B |
| Current Liabilities | $6.0B | $5.5B | $6.3B | $5.9B | $3.4B | $3.2B | $3.3B | $5.0B |
| Stockholders' Equity | $18.9B | $17.6B | $15.6B | $14.0B | $10.2B | $9.3B | $9.8B | $8.0B |
| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.6B | $7.2B | $5.1B | $7.7B | $3.0B | $1.5B | $3.9B | $4.7B |
| Investing Cash Flow | $-4.5B | $-5.0B | $-3.4B | $-2.0B | $-1.3B | $-2.1B | $-5.0B | $-1.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.9B | $-3.3B | $-1.6B | $-1.3B | $-0.1B | $-1.6B | $0.9B | $-3.1B |